| 中國醫藥大學 |
2012-04 |
Combating antimicrobial resistance: Antimicrobial stewardship program in Taiwan. J Microbiol Immunol Infect
|
(Tseng SH);(Lee CM);(Lin TY);(Chang SC);(Chuang YC);(Yen MY);黃高彬(Kao-Pin Hwang);(Leu HS);(Yen CC);(Chang FY)* |
| 中國醫藥大學 |
2008-08-29 |
COMBATING COUNTERFEIT MEDICINES IN TAIWAN
|
謝右文(Yow-Wen Hsieh); 鄭奕帝(Yih-Dih Cheng); (Chiung-Hui Tseng); (Shin-Tarng Deng); (Chi-Chow Liao) |
| 國立成功大學 |
2021-08 |
Combating COVID-19 during Airway Management: Validation of a Protection Tent for Containing Aerosols and Droplets
|
Weng;Chen-Hsun;Chiu;Po-Wei;Kao;Chia-Lung;Lin;Yu-Yuan;Lin;Chih-Hao |
| 朝陽科技大學 |
2020-12-04 |
Combating Deepfakes: Multi-LSTM and Blockchain as Proof of Authenticity for Digital Media
|
Chan, Christopher Chun Ki; Kumar, Vimal; Delaney, Steven; Gochoo, Munkjargal; 陳晉祺 |
| 臺大學術典藏 |
2020-12-11T03:17:13Z |
Combating lead-time uncertainty in global supply chain's shipment-assignment: Is it wise to be risk-averse?
|
Sun, X.;Chung, S.-H.;Choi, T.-M.;Sheu, J.-B.;Ma, H.L.; Sun, X.; Chung, S.-H.; Choi, T.-M.; Sheu, J.-B.; Ma, H.L.; JIUH-BIING SHEU |
| 臺大學術典藏 |
2022-05-30T07:08:57Z |
Combating lead-time uncertainty in global supply chain's shipment-assignment: Is it wise to be risk-averse?
|
Sun X., Chung S.-H., Choi T.-M., Sheu J.-B., Ma H.L.; Sun X.; Chung S.-H.; Choi T.-M.; Sheu J.-B.; Ma H.L.; TSAN MING CHOI |
| 國立交通大學 |
2015-12-02T02:59:40Z |
Combating Software Piracy in Public Clouds
|
Wang, Chia-Wei; Cho, Michael Cheng Yi; Wang, Chi-Wei; Shieh, Shiuhpyng Winston |
| 中國文化大學 |
2022 |
Combating stereotype threat toward athletes’ academic performance: experiments on identity safety and self-complexity
|
Hsu, Yawen; Lin, Tesu Yi; Lu, Frank J. H. |
| 國立政治大學 |
2016-09 |
Combative or Conservative: Organizational Positivity Climate and Firms' Competitive Behavior
|
顏孟賢; Chen, Forrence Hsin-Hung;Yen, Meng-Hsien Raymond |
| 臺北醫學大學 |
2009 |
Combatting Malnutrition in HIV/AIDS Patients through Local Food Consumption
|
Nurpudji Astuti Daud; Waode Salma; Djunaidi Dahlan; Abu Bakar Tawali |
| 臺大學術典藏 |
2021-05-06T08:31:00Z |
Combination alpha blocker and phosphodiesterase 5 inhibitor versus alpha-blocker monotherapy for lower urinary tract symptoms associated with benign prostate hyperplasia: A systematic review and meta-analysis
|
Chen P.-C.;Wang C.-C.;Yu-Kang Tu; Chen P.-C.; Wang C.-C.; YU-KANG TU |
| 臺大學術典藏 |
2022-05-10T08:09:45Z |
Combination alpha blocker and phosphodiesterase 5 inhibitor versus alpha-blocker monotherapy for lower urinary tract symptoms associated with benign prostate hyperplasia: A systematic review and meta-analysis
|
Chen P.-C.; Wang C.-C.; YU-KANG TU |
| 臺大學術典藏 |
2018-09-10T08:28:29Z |
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: A case report and literature review
|
Liu, J.-Y. and Chen, W.-T. and Ko, B.-S. and Yao, M. and Hsueh, P.-R. and Hsiao, C.-H. and Kuo, Y.-M. and Chen, Y.-C.; PO-REN HSUEH; BOR-SHENG KO; YEE-CHUN CHEN; MING YAO |
| 臺大學術典藏 |
2020-03-27T05:29:32Z |
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: A case report and literature review
|
Chen Y.-C.;Kuo Y.-M.;Hsiao C.-H.;PO-REN HSUEH;Yao M.;Ko B.-S.;Chen W.-T.;Liu J.-Y.; Liu J.-Y.; Chen W.-T.; Ko B.-S.; Yao M.; PO-REN HSUEH; Hsiao C.-H.; Kuo Y.-M.; Chen Y.-C. |
| 臺大學術典藏 |
2011 |
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: A case report and literature review
|
Hsiao C.-H.; Yao M.; Hsueh P.-R.; Ko B.-S.; Chen W.-T.; Liu J.-Y.; Kuo Y.-M.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2020-12-18T08:38:16Z |
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: A case report and literature review
|
Chen Y.-C.; Kuo Y.-M.; Hsiao C.-H.; PO-REN HSUEH; Yao M.; Ko B.-S.; Chen W.-T.; Liu J.-Y.;Chen W.-T.;Ko B.-S.;Yao M.;Po-Ren Hsueh;Hsiao C.-H.;Kuo Y.-M.;Chen Y.-C.; Liu J.-Y. |
| 臺大學術典藏 |
2021-05-06T01:52:23Z |
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: A case report and literature review
|
Liu J.-Y.; Chen W.-T.; Ko B.-S.; Yao M.; Hsueh P.-R.; Hsiao C.-H.; Kuo Y.-M.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2011 |
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: A case report and literature review
|
Chen Y.-C.; Kuo Y.-M.; Liu J.-Y.; Chen W.-T.; Ko B.-S.; MING YAO; Hsueh P.-R.; Hsiao C.-H. |
| 國立臺灣大學 |
2013 |
Combination antimicrobial therapy: state of art
|
Hsueh, P. -R.; 薛博仁 |
| 國立成功大學 |
2006-09 |
Combination antipsychotic therapy in psychiatric outpatient clinics in Taiwan
|
Huang, Si-Sheng; Liao, Yi-Cheng; Hsieh, Yen-Yuh; Huang, Chin-Yi; Chiu, Nan-Ying; Yang, Yen-Kuang; Shen, Winston W. |
| 國立臺灣海洋大學 |
2006 |
Combination Cancer Therapy by Hapten-Targeted Prodrug-Activating Enzymes and Cytokines
|
Kuo-Hsiang Chuang;Chiu-Min Cheng;Steve R. Roffler ;Yu-Lin Lu;Shiu-Ru Lin;Jaw-Yuan Wang;Wen-Shyong Tzou;Yu-Cheng Su;Bing-Mae Chen;Tian-Lu Cheng |
| 國立成功大學 |
2007-11 |
Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: Four case reports and an in vitro combination synergy study
|
Lee, Nan-Yao; Wang, Chun-Lung; Chuang, Yin-Ching; Yu, Wen-Liang; Lee, Hsin-Chun; Chang, Chia-Ming; Wang, Li-Rong; Ko, Wen-Chien |
| 國立臺灣大學 |
2001 |
Combination Chemotherapy of Cisplatin, Methotrexate, Vinblastine, and High-Dose Tamoxifen for Transitional Cell Carcinoma
|
徐志宏; 陳淳; 鄭安理; 蒲永孝; HSU, CHIH-HUNG; CHEN, JUN; CHENG, ANN-LII; PU, YEONG-SHIAU |
| 臺大學術典藏 |
2020-04-28T07:25:40Z |
Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma
|
Chih-Hung Hsu;Chen J.;Wu C.-Y.;Cheng A.-L.;Pu Y.-S.; CHIH-HUNG HSU; Chen J.; Wu C.-Y.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T00:47:06Z |
Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma
|
Hsu C.-H.;Chen J.;Wu C.-Y.;Cheng A.-L.;Yeong-Shiau Pu; Hsu C.-H.; Chen J.; Wu C.-Y.; Cheng A.-L.; YEONG-SHIAU PU |
